Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Allard, Matthew D ^a   Saeedi, Ramesh ^a   Yousefi, Masoud ^a   Frohlich, Jiri ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiovascular disease (CVD); Familial hypercholesterolemia; Gender differences and ethnicity; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ETHNIC GROUP; ETHNICITY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT RISK; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; STRATIFICATION; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84900515167     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-65     Document Type: Article

References (17)

1. DeMott K, Nherera L, Shaw E, Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia London: National Collaborating Centre for Primary Care and Royal College of General Practitioners 2008
2. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients. Goldberg A, Hopkins P, Toth P, Ballantyne C, Rader D, Robinson J, Daniels S, Gidding S, de Ferranti S, Ito M, McGowan M, Moriarty P, Cromwell W, Ross J, Ziajka P, J Clin Lipid 2011 5 1 S8 10.1016/j.jacl.2011. 04.003
3. Efficacy of statins in familial hypercholesterolemia: a long term cohort study. Vermissen J, Oosterveer D, Yazdanpanah M, Defesche J, Basart D, Liem A, Heeringa J, Witteman J, Lansberg P, Kastelein J, Sijbrands E, BMJ 2008 337 2423 10.1136/bmj.a2423 19001495
4. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Civeira F, Atherosclerosis 2004 173 55 68 10.1016/j.atherosclerosis.2003.11.010 15177124 (Pubitemid 38224196)
5. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. de Jongh S, Lilien M, Bakker H, Hutten B, Kastelein J, Stroes E, Atherosclerosis 2002 163 193 197 10.1016/S0021-9150(02)00003-5 12048139 (Pubitemid 34615743)
6. Lipoprotein (a) is and independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia. Holmes D, Schick B, Humphries K, Frohlich J, J Clin Chem 2005 51 2067 2073 10.1373/clinchem.2005.055228 (Pubitemid 41532622)
7. Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease. Frohlich J, Dobiasova M, Adler L, Francis M, Physiol Res 2004 53 481 486 15479125 (Pubitemid 39486704)
8. Lipoprotein (a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia. Nenseter M, Lindvig H, Ueland T, Atherosclerosis 2011 216 426 432 10.1016/j.atherosclerosis.2011.02.007 21376325
9. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. Jansen A, van Aalst-Cohen E, Tanck M, Trip M, Lansberg P, Liem AH, Roeters Van Lennep HW, Sijbrands EJ, Kastelein J, J Intern Med 2004 256 482 490 10.1111/j.1365-2796.2004.01405.x 15554949 (Pubitemid 39577582)
10. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia. De Sauvage NP, Defesche J, Buirma R, Hutten B, Lansberg P, Kastelein J, J Intern Med 2003 253 161 168 10.1046/j.1365-2796.2003.01070.x 12542556 (Pubitemid 36197536)
11. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Hill J, Hayden M, Frohlich J, Pritchard H, Arterioscler Thromb 1991 11 290 297 10.1161/01.ATV.11.2.290 1998646
12. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Ferrières J, Lambert D, Lussier-Cacan J, Davignon J, Circulation 1995 92 290 295 10.1161/01.CIR.92.3. 290 7634440
13. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia. Jansen A, van Aalst-Cohen E, Tanck M, Cheng S, Fontecha M, Li J, Defesche J, Kastelein J, Arterioscler Thromb Vasc Biol 2005 25 1475 1481 10.1161/01.ATV.0000168909.44877.a7 15879303 (Pubitemid 40923371)
14. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors. Alonso R, Mata N, Castillo S, Fuentes F, Saenz P, Muñiz O, Atherosclerosis 2008 200 315 321 10.1016/j.atherosclerosis.2007.12.024 18243212
15. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. Humphries S, Whittall R, Hubbart C, Maplebeck S, Cooper J, Soutar A, J Med Genet 2006 43 943 949 10.1136/jmg.2006.038356 17142622 (Pubitemid 46080192)
16. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Hopkins P, Stephenson S, Wu L, Riley W, Xin Y, Hunt S, Am J Cardiol 2001 87 547 553 10.1016/S0002-9149(00)01429-6 11230837 (Pubitemid 32178448)
17. Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia. Neil H, Seagroatt V, Betteridge D, Cooper M, Durrington P, Miller J, Seed M, Naoumova R, Thompson G, Huxley R, Humphies S, Heart 2004 90 1431 1437 10.1136/hrt.2003.022764 15547022 (Pubitemid 39626319)